Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin.
about
Structures of a potent phenylalkyl bisphosphonate inhibitor bound to farnesyl and geranylgeranyl diphosphate synthasesHIV-1 Integrase Inhibitor-Inspired Antibacterials Targeting Isoprenoid BiosynthesisTaxodione and arenarone inhibit farnesyl diphosphate synthase by binding to the isopentenyl diphosphate siteNuclear magnetic resonance-based quantification of organic diphosphates.Undecaprenyl diphosphate synthase inhibitors: antibacterial drug leads.Sub-inhibitory fosmidomycin exposures elicits oxidative stress in Salmonella enterica serovar Typhimurium LT2.Non-bisphosphonate inhibitors of isoprenoid biosynthesis identified via computer-aided drug design.An enzyme-coupled continuous fluorescence assay for farnesyl diphosphate synthasesAntibacterial drug leads: DNA and enzyme multitargetingTargeting DXP synthase in human pathogens: enzyme inhibition and antimicrobial activity of butylacetylphosphonate.Versatile (1)H-(31)P-(31)P COSY 2D NMR techniques for the characterization of polyphosphorylated small molecules.Isoprenoid Biosynthesis Inhibitors Targeting Bacterial Cell Growth.Specificity of the zinc(II), magnesium(II) and calcium(II) complexation by (pyridin-2-yl)aminomethane-1,1-diphosphonic acids and related 1,3-(thiazol-2-yl) and 1,3-(benzothiazol-2-yl) derivatives.Growth medium-dependent antimicrobial activity of early stage MEP pathway inhibitors.
P2860
Q27650471-B3FD7DEA-FA4E-4D9F-A930-2A36C670C335Q27679484-857C5748-AF34-459E-B4AF-ADF2ACABDE5DQ27684323-E92AFFBA-FD68-495B-A34E-DDC0CDF01857Q33690290-5E7E0AB1-692B-4970-9591-251E2E8BF5F0Q33894595-B0F46C3A-66E1-4E5C-9419-741C4C0088CAQ35153938-7B9AB2CF-A25C-4FE3-B863-3841C5E0472AQ35163073-8C3254A4-BD4C-4D07-892E-002222843A21Q35870322-96C9121C-9514-4A27-AFAC-934AA7394902Q35886164-84E25DA2-B86B-4C9B-9E64-991F6FC79B55Q37625209-7F62A0E0-F885-4484-BEF2-BB45E11E7C25Q40692499-2929B308-6B20-4D40-BC03-63DF6F9174D1Q42351008-98CB7973-9CC6-44B4-B575-CD53A03FB60EQ43183249-A1947255-8367-4239-B23B-95432268F980Q55093817-CB7AB570-3564-477D-9D47-4497A301AFCF
P2860
Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Isoprenoid biosynthesis as a d ...... istic effects of fosmidomycin.
@ast
Isoprenoid biosynthesis as a d ...... istic effects of fosmidomycin.
@en
Isoprenoid biosynthesis as a d ...... istic effects of fosmidomycin.
@nl
type
label
Isoprenoid biosynthesis as a d ...... istic effects of fosmidomycin.
@ast
Isoprenoid biosynthesis as a d ...... istic effects of fosmidomycin.
@en
Isoprenoid biosynthesis as a d ...... istic effects of fosmidomycin.
@nl
prefLabel
Isoprenoid biosynthesis as a d ...... istic effects of fosmidomycin.
@ast
Isoprenoid biosynthesis as a d ...... istic effects of fosmidomycin.
@en
Isoprenoid biosynthesis as a d ...... istic effects of fosmidomycin.
@nl
P2093
P356
P1476
Isoprenoid biosynthesis as a d ...... istic effects of fosmidomycin.
@en
P2093
Annette Leon
Craig T Morita
Danielle Studer
Eric Oldfield
Fenglin Yin
Kia-Joo Puan
Michael P Hudock
Patrick Hall
P304
P356
10.1021/JM060492B
P407
P577
2006-12-01T00:00:00Z